U

UCB PHARMA (Public limited company)

BE 0403.096.168 Active ●Allée de la Recherche 60, 1070 Anderlecht

UCB PHARMA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0403.096.168. It was founded on 01-02-1968. Its registered office is in Anderlecht. Its main activity is: Wholesale trade. Its annual accounts for 2025 report equity of € 16 234 819 937 and a profit of € 4 239 651 764. These accounts report 1960.6 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0403.096.168
VAT registered
Yes
Founded
01-02-1968
Latest accounts
2025
Employees
1960.6 FTE
Region
Brussels-Capital
Establishments
3
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Allée de la Recherche 60, 1070 Anderlecht
Main activity
Wholesale trade
NACE activities
46460 Commerce de gros de produits pharmaceutiques et médicaux
21201 Fabrication de médicaments

Key figures of UCB PHARMA

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 4 239 651 764+347 %€ 947 428 300+1 %€ 938 115 520
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 16 234 819 937+31 %€ 12 395 168 174+5 %€ 11 797 739 873
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 20 742 385 083+26 %€ 16 414 794 946+8 %€ 15 197 496 330
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
---
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
1960.6+12 %1746.4+19 %1464.4

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
4 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Anderlecht.

CompanyTown
Popelin Apotheken 1070 Anderlecht
CLUB 1070 Anderlecht
ELECTRO DEPOT BELGIUM 1070 Anderlecht
HILTI BELGIUM 1070 Anderlecht
DMC BRUSSELS 1070 Anderlecht
NESPRESSO BELGIQUE ou NESPRESSO BELGIE 1070 Anderlecht
COCA-COLA EUROPACIFIC PARTNERS BELGIUM 1070 Anderlecht
Roger Rachin 1070 Anderlecht
Looking for more information about UCB PHARMA?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is UCB PHARMA still active? Yes. The Crossroads Bank for Enterprises lists UCB PHARMA as active.

What is the VAT number of UCB PHARMA? The VAT number of UCB PHARMA is BE 0403.096.168.

When was UCB PHARMA founded? UCB PHARMA was founded on 01-02-1968.

What is the address of UCB PHARMA? The current registered office of UCB PHARMA is Allée de la Recherche 60, 1070 Anderlecht.

When did UCB PHARMA last file annual accounts? The latest annual accounts of UCB PHARMA were filed on 19-05-2026.

Does UCB PHARMA file its annual accounts on time? Yes. UCB PHARMA filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does UCB PHARMA have? UCB PHARMA employs 1960.6 full-time equivalents according to its most recent annual accounts.

Is UCB PHARMA financially healthy? Addrly gives UCB PHARMA a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is UCB PHARMA profitable? The annual accounts of UCB PHARMA for 2025 show a profit of € 4 239 651 764.

What is the equity of UCB PHARMA? The equity of UCB PHARMA was € 16 234 819 937 at the close of the 2025 financial year.

Who are the directors of UCB PHARMA? The annual accounts of UCB PHARMA record 4 mandates. The names, roles and dates are visible with a free account.

Can UCB PHARMA receive Peppol e-invoices? Yes. UCB PHARMA is registered on the Peppol network and can receive structured electronic invoices.

What does UCB PHARMA do? The main activity of UCB PHARMA is: Wholesale trade.

Sources

How Addrly builds and refreshes this data